Nectar Lifesciences informs about disclosure

10 Jan 2025 Evaluate
Nectar Lifesciences has informed that the exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ingain Traders LLC, Vedanta Opportunities Fund LP, Isengard Direct PE LLC.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

14.58 0.69 (4.97%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×